Celgene Wins Patent Row, Gets Generic Rival

18.02.2019 - Within a week, US biotech Celgene, which is in the process of being acquired by Bristol-Myers-Squibb (BMS), dodged a challenge to its patent for the blockbuster multiple myeloma...